SQ 33,961 IS A POTENT, LONG-ACTING, ORALLY ACTIVE THROMBOXANE RECEPTOR ANTAGONIST WITH WEAK THROMBOXANE A SYNTHASE INHIBITORY ACTIVITY

被引：0
作者：
OGLETREE, ML [1 ]
HARRIS, DN [1 ]
SCHUMACHER, WA [1 ]
GOLDENBERG, HJ [1 ]
MICHEL, IM [1 ]
OKEEFE, EH [1 ]
ALLEN, GT [1 ]
HERAN, CL [1 ]
STEINBACHER, TE [1 ]
机构：
[1] BRISTOL MYERS SQUIBB PHARMACEUT RES INST,PRINCETON,NJ
来源：
THROMBOSIS AND HAEMOSTASIS | 1991年 / 65卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1143 / 1143
页数：1
相关论文
共 32 条
  • [1] INTERPHENYLENE 7-OXABICYCLOHEPTANES-2 SQ-33,961 - A NEW POTENT, SELECTIVE, LONG-ACTING TXA2 ANTAGONIST
    MISRA, RN
    BROWN, BR
    SHER, PM
    PATEL, MM
    HAN, WC
    BARRISH, JC
    HALL, SE
    HARRIS, DN
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1991, 201 : 73 - MEDI
  • [2] PHARMACOLOGICAL PROFILE OF BMS-180,291 - A POTENT, LONG-ACTING, ORALLY ACTIVE THROMBOXANE-A2/PROSTAGLANDIN-ENDOPEROXIDE RECEPTOR ANTAGONIST
    OGLETREE, ML
    HARRIS, DN
    SCHUMACHER, WA
    WEBB, ML
    MISRA, RN
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 264 (02) : 570 - 578
  • [3] PHARMACOLOGICAL CHARACTERIZATION OF POTENT, LONG-ACTING THROMBOXANE RECEPTOR ANTAGONISTS, SQ-33,261 AND SQ-33,552
    HARRIS, DN
    MICHEL, IM
    GOLDENBERG, HJ
    HARTL, KS
    ALLEN, GT
    STEINBACHER, TE
    SCHUMACHER, WA
    HAN, WC
    HALL, SE
    FLOYD, DM
    OGLETREE, ML
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 261 (01) : 131 - 137
  • [4] ICI 192605 - A POTENT, SELECTIVE THROMBOXANE RECEPTOR ANTAGONIST IS ORALLY ACTIVE IN MAN
    JESSUP, CL
    JESSUP, R
    STARK, RD
    WILLIAMS, C
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 (05) : P710 - P710
  • [5] INTERPHENYLENE 7-OXABICYCLO[2.2.1]HEPTANES - SQ-33961 - A NEW POTENT, LONG-ACTING THROMBOXANE ANTAGONIST
    MISRA, RN
    BROWN, BR
    SHER, PM
    PATEL, MM
    GOLDENBERG, HJ
    MICHEL, IM
    HARRIS, DN
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1991, 1 (09) : 461 - 464
  • [6] A long-acting prostacyclin agonist with thromboxane inhibitory activity for pulmonary hypertension
    Kataoka, M
    Nagaya, N
    Satoh, T
    Itoh, T
    Murakami, S
    Iwase, T
    Miyahara, Y
    Kyotani, S
    Sakai, Y
    Kangawa, K
    Ogawa, S
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (12) : 1575 - 1580
  • [7] ANTIPLATELET ACTIVITY OF THE LONG-ACTING THROMBOXANE RECEPTOR ANTAGONIST BMS-180,291 IN MONKEYS
    SCHUMACHER, WA
    STEINBACHER, TE
    YOUSSEF, S
    OGLETREE, ML
    PROSTAGLANDINS, 1992, 44 (05): : 389 - 397
  • [8] CGS 22652 - A NEW POTENT THROMBOXANE-A2 RECEPTOR ANTAGONIST WITH SELECTIVE THROMBOXANE-A2 SYNTHASE INHIBITORY PROPERTIES
    COHEN, DS
    MCMARTIN, DN
    MARIETTA, MP
    ZANE, PA
    LAPPE, RW
    CARDIOVASCULAR DRUG REVIEWS, 1992, 10 (04): : 379 - 391
  • [9] Oral Administration of a Novel Long-Acting Prostacyclin Agonist With Thromboxane Synthase Inhibitory Activity for Pulmonary Arterial Hypertension
    Nakamura, Atsuhiro
    Nagaya, Noritoshi
    Obata, Hiroaki
    Sakai, Katsuya
    Sakai, Yoshiki
    Yoshikawa, Masanori
    Hamada, Kaoru
    Matsumoto, Kunio
    Kimura, Hiroshi
    CIRCULATION JOURNAL, 2013, 77 (08) : 2127 - 2133
  • [10] PROTECTIVE EFFECTS OF POTENT, LONG-ACTING THROMBOXANE RECEPTOR ANTAGONISTS, SQ 33,261 AND SQ 33,552, AGAINST U 46,619-INDUCED SUDDEN-DEATH IN MICE
    HARRIS, DN
    MICHEL, IM
    GOLDENBERG, HJ
    ALLEN, GT
    HALL, SE
    FLOYD, DM
    OGLETREE, ML
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 311 - 311
1234